Recruiting NA Breastfeeding

New treatment option for Breastfeeding

Official title Father-Focused Breastfeeding Education and Breastfeeding Outcomes

ClinicalTrials.gov ID: NCT07341256

What this study is testing

What it's testing
Breastfeeding is recommended as the optimal feeding method for infants during the first six months of life. Support from fathers or partners plays an important role in initiating and maintaining breastfeeding.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Fathers or partners aged 18 years or older.
  • Fathers or partners of healthy term newborns (≥37 weeks gestation).
  • Newborns without major congenital anomalies or chronic medical conditions.
  • Fathers or partners present during the early postnatal period.
  • Ability to understand and communicate in Turkish.

You likely can't join if

  • Fathers or partners of preterm infants (\<37 weeks gestation).
  • Newborns requiring neonatal intensive care unit admission.
  • Newborns with major congenital anomalies or severe medical conditions.
  • Fathers or partners unable to complete follow-up assessments.
  • Refusal or inability to provide informed consent.
See the full eligibility criteria
Who can join
  • Fathers or partners aged 18 years or older.
  • Fathers or partners of healthy term newborns (≥37 weeks gestation).
  • Newborns without major congenital anomalies or chronic medical conditions.
  • Fathers or partners present during the early postnatal period.
  • Ability to understand and communicate in Turkish.
  • Provision of written informed consent.
What rules you out
  • Fathers or partners of preterm infants (\<37 weeks gestation).
  • Newborns requiring neonatal intensive care unit admission.
  • Newborns with major congenital anomalies or severe medical conditions.
  • Fathers or partners unable to complete follow-up assessments.
  • Refusal or inability to provide informed consent.

The study team makes the final eligibility decision.

Where it's taking place

  • Istanbul, Turkey (Türkiye)

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.